| [1] |
Kumarasinghe S, Pandya A, Chandran V, et al. A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis[J]. Int J Dermatol, 2019,58(3):263⁃272. DOI: 10.1111/ijd.14189.
|
| [2] |
Sarkar R, Vinay K, Bishnoi A, et al. A Delphi consensus on the nomenclature and diagnosis of lichen planus pigmentosus and related entities[J]. Indian J Dermatol Venereol Leprol, 2023,89(1):41⁃46. DOI: 10.25259/IJDVL_804_2021.
|
| [3] |
Bishnoi A, Vinay K, Arshdeep, et al. Contact sensitization to hair colours in acquired dermal macular hyperpigmentation: results from a patch and photo⁃patch test study of 108 patients[J]. J Eur Acad Dermatol Venereol, 2019,33(7):1349⁃1357. DOI: 10.1111/jdv.15576.
|
| [4] |
Kim SM, Lee ES, Sohn S, et al. Histopathological features of Riehl melanosis[J]. Am J Dermatopathol, 2020,42(2):117⁃121. DOI: 10.1097/DAD.0000000000001515.
|
| [5] |
Wang L, Xu AE. Four views of Riehl's melanosis: clinical appearance, dermoscopy, confocal microscopy and histopathology[J]. J Eur Acad Dermatol Venereol, 2014,28(9):1199⁃1206. DOI: 10.1111/jdv.12264.
|
| [6] |
Xu Z, Chen L, Jiang M, et al. CCN1/Cyr61 stimulates melanogenesis through integrin α6β1, p38 MAPK, and ERK1/2 signaling pathways in human epidermal melanocytes[J]. J Invest Dermatol, 2018,138(8):1825⁃1833. DOI: 10.1016/j.jid.2018. 02.029.
|
| [7] |
Xu Z, Xing X, Zhang C, et al. A pilot study of oral tranexamic acid and glycyrrhizin compound in the treatment of recalcitrant Riehl's melanosis[J]. J Cosmet Dermatol, 2019,18(1):286⁃292. DOI: 10.1111/jocd.12797.
|
| [8] |
Xu Z, Wang C, Xing X, et al. Efficacy and safety of the combination of oral tranexamic acid and intense pulsed light versus oral tranexamic acid alone in the treatment of refractory Riehl's melanosis: a prospective, comparative study[J]. J Cosmet Dermatol, 2024,23(6):2049⁃2057. DOI: 10.1111/jocd. 16257.
|
| [9] |
Tan JY, Zhao F, Deng SX, et al. Glycyrrhizin affects monocyte migration and apoptosis by blocking HMGB1 signaling[J]. Mol Med Rep, 2018,17(4):5970⁃5975. DOI: 10.3892/mmr.2018.8598.
|
| [10] |
Forbat E, Al⁃Niaimi F, Ali FR. The emerging importance of tranexamic acid in dermatology[J]. Clin Exp Dermatol, 2020,45(4):445⁃449. DOI: 10.1111/ced.14115.
|
| [11] |
Gold MH. Commentary: a pilot study of intense pulsed light in the treatment of Riehl's melanosis[J]. Dermatol Surg, 2011,37(1):123⁃124. DOI: 10.1111/j.1524⁃4725.2010.01812.x.
|
| [12] |
Kim MJ, Huh CH, Shin JW, et al. Low⁃dose oral isotretinoin for recalcitrant Riehl's melanosis: a retrospective case series[J]. J Dtsch Dermatol Ges, 2023,21(9):1029⁃1031. DOI: 10.1111/ddg.15141.
|
| [13] |
Araghi F, Beyki F, Rakhshan A, et al. Generalized lichen planus pigmentosus and a new management approach[J]. Clin Case Rep, 2024,12(6):e8829. DOI: 10.1002/ccr3.8829.
|